PEPTIDE

Cognitive & Neuroprotection

Peptides for Cognitive Research

Cognitive research examines peptides being studied for their potential effects on memory, learning, focus, and neuroplasticity. This page reviews current scientific literature on peptide candidates for cognitive performance and brain health research.

Last updated: 23 April 2026

What the research covers

Cognitive research investigates neuropeptides and neurotrophin-related compounds for memory enhancement, neuroprotection, and cognitive resilience. Cerebrolysin is a polyactive neuropeptide mixture studied for BDNF upregulation and neuroprotection. Semax is examined for cognitive enhancement and stress resilience. Selank is investigated for anxiety reduction and cognitive performance. Research focuses on synaptic plasticity, BDNF signalling, and cognitive outcomes.

Where the evidence is strongest

Cerebrolysin shows cognitive benefits in post-stroke and age-related cognitive decline populations, with documented BDNF increases. Semax research demonstrates improved memory and attention in human cognitive tasks, particularly in stress contexts. Selank studies suggest anxiolytic effects and improved cognitive performance in anxious populations.

Limits of the current literature

Most cognitive peptide research is concentrated in Eastern European/Russian populations; Western replication is limited. Long-term safety and efficacy in healthy cognitive populations are underexplored. Mechanisms of action at the molecular level remain partially elucidated. Head-to-head comparisons with established nootropics are sparse.

Regulatory and access considerations (Australia)

Cognitive peptides are not ARTG-approved for cognitive enhancement or nootropic use. Some (cerebrolysin) may have limited medical application pathways in Australia; most are research-use only. Prescription access is not available for cognitive optimisation. Research-grade supply is legal for institutional research.

Reviews relevant to this context

Prescription
Evidence
3.8/ 5
B+
Compound profileCognitive

Cerebrolysin

Primary research interestCognitive performance & neuroprotection research

Peptide-enriched brain extract studied and used clinically for cognitive and neurological indications.

Last reviewed1 Apr 2026
View profile
Research only
Evidence
3.4/ 5
B−
Compound profileCognitive

Semax

Primary research interestCognitive performance & neuroprotection research

Russian-origin synthetic peptide studied for cognitive and neuroprotective effects.

Last reviewed30 Mar 2026
View profile
Research only
Evidence
3.6/ 5
B
Compound profileCognitive

Selank

Primary research interestCognitive performance & neuroprotection research

Russian-origin synthetic peptide studied for anxiolytic and cognitive effects.

Last reviewed26 Feb 2026
View profile
Research only
Evidence
3.2/ 5
B−
Compound profileSleep

DSIP

Primary research interestSleep architecture & circadian research

Delta-sleep-inducing peptide with a long research history but limited modern human evidence.

Last reviewed4 Feb 2026
View profile
Research only
Evidence
3.6/ 5
B
Compound profileCognitive

Selank

Primary research interestCognitive performance & neuroprotection research

Russian-origin synthetic peptide studied for anxiolytic and cognitive effects.

Last reviewed26 Feb 2026
View profile

Related comparisons

Related guides

FAQs

Cerebrolysin is a polyactive peptide mixture derived from porcine brain. Research suggests it upregulates BDNF and supports neuroprotection. Some studies document cognitive improvements in dementia and post-stroke populations, though mechanisms and long-term effects in healthy individuals are unclear.